Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose “IVIG-SN” Therapy for Pediatric Patients with Kawasaki Disease-Reference-Cited by-同舟云学术

Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose “IVIG-SN” Therapy for Pediatric Patients with Kawasaki Disease

Published:2017 Issue:2 Volume:47 Page:209
ISSN:1738-5520
Container-title:Korean Circulation Journal
language:en
Short-container-title:Korean Circ J

Author:

Yoon Kyung Lim¹,Lee Hae Yong¹,Yu Jeong Jin²,Lee Jae Young³,Han Mi Young⁴,Kim Ki Yong⁵,Huh June⁶

Affiliation:

1. Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul, Korea.

2. Division of Pediatric Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

3. Division of Cardiology, Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

4. Department of Pediatrics, Kyung Hee University Hospital, Seoul, Korea.

5. Green Cross Corporation, Seoul, Korea.

6. Division of Cardiology, Department of Pediatrics, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Funder

Green Cross Corporation

Publisher

The Korean Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://synapse.koreamed.org/pdf/10.4070/kcj.2016.0139

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current IgG Products and Future Perspectives;Antibody Therapy;2017-10-19

2. The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?;Korean Circulation Journal;2017